We are a start-up life science company founded by cancer researchers from Karolinska Institutet and Linköping University.
Developing new cancer therapies for patients with high-risk tumors
Originate from cancer research at Karolinska Institutet
We develop candidate drugs for a new cancer therapy.
We are a drug development company that focus on targeting the MYC oncoprotein, the main driver of more than 50% of all cancers.
Our vision is a new cancer therapy for patients with aggressive, resistant, metastazised high-risk tumors.
We want to give patients with non curable cancer an option in the future.
Our mission is to develop potential candidate drugs targeting the MYC oncoprotein.
Small molecules targeting MYC were identified by cancer researchers at Karolinska Instiutet and are now being developed by MyCural Therapeutics.
Our vision is to create a new cancer therapy
Our vision is to develop a new cancer therapy for patients with high-risk tumors